Full Name
Ko, T.K.
Variants
Ko, T.K.
 
 
Email
gmsktk@nus.edu.sg
 

Publications

Results 1-6 of 6 (Search time: 0.008 seconds).

Issue DateTitleAuthor(s)
1Apr-2012A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancerNg, K.P.; Hillmer, A.M.; Chuah, C.T.H.; Juan, W.C.; Ko, T.K. ; Teo, A.S.M.; Ariyaratne, P.N.; Takahashi, N.; Sawada, K.; Fei, Y.; Soh, S.; Lee, W.H.; Huang, J.W.J.; Allen Jr., J.C.; Woo, X.Y.; Nagarajan, N.; Kumar, V.; Thalamuthu, A.; Poh, W.T.; Ang, A.L.; Mya, H.T.; How, G.F.; Yang, L.Y.; Koh, L.P.; Chowbay, B.; Chang, C.-T.; Nadarajan, V.S.; Chng, W.J.; Than, H.; Lim, L.C.; Goh, Y.T.; Zhang, S.; Poh, D.; Tan, P. ; Seet, J.-E.; Ang, M.-K.; Chau, N.-M.; Ng, Q.-S.; Tan, D.S.W.; Soda, M.; Isobe, K.; Nöthen, M.M.; Wong, T.Y. ; Shahab, A.; Ruan, X.; Cacheux-Rataboul, V.; Sung, W.-K.; Tan, E.H.; Yatabe, Y.; Mano, H.; Soo, R.A. ; Chin, T.M. ; Lim, W.-T.; Ruan, Y. ; Ong, S.T.
22010Claudin-1 Has Tumor Suppressive Activity and Is a Direct Target of RUNX3 in Gastric Epithelial CellsChang, T.L. ; Ko, T.K. ; Liu, Q.; Salto-Tellez, M. ; Ito, Y. ; Ito, K. ; Yeoh, K.G. ; Fukamachi, H.
32006RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancerLau, Q.C. ; Raja, E.; Salto-Tellez, M. ; Liu, Q. ; Ito, K. ; Inoue, M. ; Ko, T.K. ; Huang, C. ; Ito, Y. ; Sukumar, S. ; Putti, T.C. ; Loh, M.; Inoue, M.; Ito, Y. ; Bhalla, K.N.; Zhu, T.
42014The BCL2 inhibitor ABT-199 significantly enhances imatinib-induced cell death in chronic myeloid leukemia progenitorsKo T.K. ; Chuah C.T. ; Huang J.W.; Ng K.-P. ; Ong S.T. 
52016The BIM deletion polymorphism: A paradigm of a permissive interaction between germline and acquired TKI resistance factors in chronic myeloid leukemiaKo T.K. ; Chin H.S. ; Chuah C.T.H. ; Huang J.W.J.; Ng K.-P. ; Khaw S.L.; Huang D.C.S.; Ong S.T.
62017The HDAC inhibitor SB939 overcomes resistance to BCR-ABL kinase Inhibitors conferred by the BIM deletion polymorphism in chronic myeloid leukemiaRauzan M. ; Chuah C.T.H. ; Ko T.K. ; Tiong Ong S.